Nour-El-Houda Mourksi

Years Active: 2022-2022
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Nour-El-Houda Mourksi, Cécile Dalban, Amélie Colombe-Vermorel, Laetitia Odeyer, Valentin Simioni, Jean-Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie-Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone-Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Pérol, Isabelle Ray-Coquard, Pierre-Etienne Heudel, Jean-Jacques Diaz, Virginie Marcel
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group. Molecular oncology (2022)

Nour-El-Houda Mourksi.css-eqlu8i{font-size:small;padding-left:4px;}